Holen Sie sich die Stockscreener-App
14.41
0.69%
-0.10
Handel nachbörslich:
14.39
-0.02
-0.14%
Schlusskurs vom Vortag:
$14.51
Offen:
$14.49
24-Stunden-Volumen:
453.13K
Relative Volume:
0.35
Marktkapitalisierung:
$910.84M
Einnahmen:
$492.05M
Nettoeinkommen (Verlust:
$197.92M
KGV:
6.2652
EPS:
2.3
Netto-Cashflow:
$176.12M
1W Leistung:
-3.42%
1M Leistung:
+2.42%
6M Leistung:
-23.43%
1J Leistung:
-6.61%
1-Tages-Spanne:
$14.28
$14.49
1-Wochen-Bereich:
$14.28
$15.02
52-Wochen-Spanne:
$13.14
$19.85
Inmode Ltd Stock (INMD) Company Profile
Vergleichen Sie INMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.41 | 910.84M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-02-17 | Herabstufung | Needham | Buy → Hold |
| 2022-12-21 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-05-18 | Eingeleitet | Needham | Buy |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
Do Options Traders Know Something About InMode Stock We Don't? - Yahoo Finance
Real time pattern detection on InMode Ltd. stockMarket Performance Summary & Weekly High Conviction Ideas - Newser
What to expect from InMode Ltd. in the next 30 daysWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
When is the best time to exit InMode Ltd.2025 Valuation Update & Safe Capital Growth Tips - Newser
Risk vs reward if holding onto InMode Ltd.July 2025 PreEarnings & Verified Technical Trade Signals - Newser
What data driven models say about InMode Ltd.’s futureWeekly Stock Recap & AI Driven Price Predictions - Newser
What’s next for InMode Ltd. stock price2025 Top Gainers & Verified Entry Point Signals - Newser
How to build a custom watchlist for InMode Ltd.Portfolio Gains Summary & Expert Curated Trade Setups - Newser
Published on: 2025-09-03 03:01:23 - Newser
How to use Fibonacci retracement on InMode Ltd.July 2025 Weekly Recap & Advanced Swing Trade Entry Plans - Newser
Signal strength of InMode Ltd. stock in tech scannersJuly 2025 Drop Watch & Long-Term Safe Return Strategies - Newser
Tools to monitor InMode Ltd. recovery probability2025 Year in Review & Expert Verified Movement Alerts - Newser
Using Python tools to backtest InMode Ltd. strategiesMarket Rally & Weekly Stock Performance Updates - Newser
Using flow based indicators on InMode Ltd.July 2025 Catalysts & Entry and Exit Point Strategies - Newser
How sentiment analysis helps forecast InMode Ltd.2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Tick level data insight on InMode Ltd. volatilityJuly 2025 Update & Accurate Intraday Trading Signals - Newser
What is InMode Ltd. s P E ratio telling us2025 Earnings Surprises & Technical Analysis for Trade Confirmation - khodrobank.com
InMode to Present at Baird 2025 Global Healthcare Conference - StreetInsider
Medical Tech Leader InMode Takes Center Stage at Baird 2025 Global Healthcare Conference in NYC - Stock Titan
Market reaction to InMode Ltd.’s recent newsProduct Launch & Advanced Technical Signal Analysis - Newser
Reversal indicators forming on InMode Ltd. stockJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
How to integrate InMode Ltd. into portfolio analysis toolsForecast Cut & Growth-Oriented Investment Plans - Newser
Will InMode Ltd. price bounce be sustainableSwing Trade & Safe Entry Point Alerts - Newser
Full technical analysis of InMode Ltd. stockMarket Volume Summary & Fast Moving Trade Plans - Newser
Is InMode Ltd. stock a value trapDip Buying & AI Powered Buy/Sell Recommendations - خودرو بانک
Is InMode Ltd. stock heavily shortedJuly 2025 Catalysts & Safe Entry Zone Tips - khodrobank.com
Will InMode Ltd. outperform the marketCEO Change & Verified Technical Signals - Newser
How institutional ownership impacts InMode Ltd. stock2025 Technical Overview & High Accuracy Swing Entry Alerts - Newser
Leading vs lagging indicators on InMode Ltd. performanceWeekly Trading Summary & Real-Time Volume Analysis - Newser
Quantitative breakdown of InMode Ltd. recent moveQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Combining machine learning predictions for InMode Ltd.CPI Data & Weekly Breakout Watchlists - Newser
Strategies to average down on InMode Ltd.July 2025 Levels & Low Risk High Reward Trade Ideas - Newser
What machine learning models say about InMode Ltd.Earnings Summary Report & Free AI Powered Buy and Sell Recommendations - Newser
InMode Ltd. stock outlook for YEARQuarterly Profit Review & Low Risk Entry Point Guides - Newser
Using Bollinger Bands to evaluate InMode Ltd.2025 Top Decliners & Safe Swing Trade Setups - Newser
Is InMode Ltd. stock entering bullish territoryDip Buying & Safe Swing Trade Setups - Newser
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):